Forus Balance Sheet Health

Financial Health criteria checks 5/6

Forus has a total shareholder equity of CLP235.7B and total debt of CLP2.7B, which brings its debt-to-equity ratio to 1.2%. Its total assets and total liabilities are CLP333.6B and CLP97.9B respectively. Forus's EBIT is CLP36.2B making its interest coverage ratio 9.2. It has cash and short-term investments of CLP71.3B.

Key information

1.2%

Debt to equity ratio

CL$2.74b

Debt

Interest coverage ratio	9.2x
Cash	CL$71.29b
Equity	CL$235.65b
Total liabilities	CL$97.94b
Total assets	CL$333.59b

Recent financial health updates

Recent updates

Forus (SNSE:FORUS) Is Investing Its Capital With Increasing Efficiency

Jan 02

Is It Time To Consider Buying Forus S.A. (SNSE:FORUS)?

Oct 26

Is Forus (SNSE:FORUS) Using Too Much Debt?

Sep 01

Upgrade: Analysts Just Made A Sizeable Increase To Their Forus S.A. (SNSE:FORUS) Forecasts

May 25

Is It Time To Consider Buying Forus S.A. (SNSE:FORUS)?

Mar 18

Return Trends At Forus (SNSE:FORUS) Aren't Appealing

Jan 27

Does Forus (SNSE:FORUS) Have A Healthy Balance Sheet?

Nov 05

Is Now The Time To Look At Buying Forus S.A. (SNSE:FORUS)?

Jun 14

Returns On Capital At Forus (SNSE:FORUS) Paint A Concerning Picture

May 06

Forus (SNSE:FORUS) Has A Pretty Healthy Balance Sheet

Mar 23

At CL$1,405, Is Forus S.A. (SNSE:FORUS) Worth Looking At Closely?

Mar 01

A Look At Forus' (SNSE:FORUS) Share Price Returns

Jan 27

Forus (SNSE:FORUS) Seems To Use Debt Quite Sensibly

Dec 23

At CL$1,099, Is It Time To Put Forus S.A. (SNSE:FORUS) On Your Watch List?

Nov 18

Financial Position Analysis

Short Term Liabilities: FORUS's short term assets (CLP206.2B) exceed its short term liabilities (CLP54.5B).

Long Term Liabilities: FORUS's short term assets (CLP206.2B) exceed its long term liabilities (CLP43.4B).

Debt to Equity History and Analysis

Debt Level: FORUS has more cash than its total debt.

Reducing Debt: FORUS's debt to equity ratio has increased from 0.5% to 1.2% over the past 5 years.

Debt Coverage: FORUS's debt is well covered by operating cash flow (2569.3%).

Interest Coverage: FORUS's interest payments on its debt are well covered by EBIT (9.2x coverage).

Forus Balance Sheet Health

Financial Health criteria checks 5/6

Key information

Recent financial health updates

Is Forus (SNSE:FORUS) Using Too Much Debt?

Does Forus (SNSE:FORUS) Have A Healthy Balance Sheet?

Forus (SNSE:FORUS) Has A Pretty Healthy Balance Sheet

Forus (SNSE:FORUS) Seems To Use Debt Quite Sensibly

Recent updates

Upcoming dividend of CL$15.50 per share

Second quarter 2024 earnings released: EPS: CL$45.00 (vs CL$36.84 in 2Q 2023)

Forus S.A. to Report Q3, 2024 Results on Nov 22, 2024

First quarter 2024 earnings released: EPS: CL$20.60 (vs CL$23.57 in 1Q 2023)

Upcoming dividend of CL$29.14 per share

Price target increased by 11% to CL$1,937

Full year 2023 earnings: Revenues exceed analyst expectations

Third quarter 2023 earnings released: EPS: CL$18.70 (vs CL$17.32 in 3Q 2022)

Upcoming dividend of CL$15.50 per share at 7.6% yield

Second quarter 2023 earnings released: EPS: CL$36.72 (vs CL$52.03 in 2Q 2022)

First quarter 2023 earnings released: EPS: CL$23.50 (vs CL$13.40 in 1Q 2022)

Upcoming dividend of CL$48.82 per share at 7.3% yield

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Forus (SNSE:FORUS) Is Investing Its Capital With Increasing Efficiency

Price target increased to CL$1,825

Third quarter 2022 earnings released: EPS: CL$17.32 (vs CL$46.85 in 3Q 2021)

Less than half of directors are independent

Is It Time To Consider Buying Forus S.A. (SNSE:FORUS)?

Investor sentiment improved over the past week

Is Forus (SNSE:FORUS) Using Too Much Debt?

Second quarter 2022 earnings released: EPS: CL$52.03 (vs CL$39.09 in 2Q 2021)

Upcoming dividend of CL$58.00 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Upgrade: Analysts Just Made A Sizeable Increase To Their Forus S.A. (SNSE:FORUS) Forecasts

Upcoming dividend of CL$45.95 per share

Price target decreased to CL$1,633

Less than half of directors are independent

Is It Time To Consider Buying Forus S.A. (SNSE:FORUS)?

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Return Trends At Forus (SNSE:FORUS) Aren't Appealing

Third quarter 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Upcoming dividend of CL$15.00 per share

Does Forus (SNSE:FORUS) Have A Healthy Balance Sheet?

Upcoming dividend of CL$116 per share

Second quarter 2021 earnings released: EPS CL$39.09 (vs CL$9.42 loss in 2Q 2020)

Is Now The Time To Look At Buying Forus S.A. (SNSE:FORUS)?

Investor sentiment improved over the past week

Upcoming dividend of CL$156 per share

First quarter 2021 earnings released: EPS CL$13.07 (vs CL$2.44 in 1Q 2020)

Returns On Capital At Forus (SNSE:FORUS) Paint A Concerning Picture

Inaugural dividend of CL$5.27 per share

Forus (SNSE:FORUS) Has A Pretty Healthy Balance Sheet

At CL$1,405, Is Forus S.A. (SNSE:FORUS) Worth Looking At Closely?

Full year 2020 earnings released: EPS CL$17.60 (vs CL$90.49 in FY 2019)

Revenue and earnings beat expectations

New 90-day high: CL$1,465

A Look At Forus' (SNSE:FORUS) Share Price Returns

New 90-day high: CL$1,250

Forus (SNSE:FORUS) Seems To Use Debt Quite Sensibly

Revenue and earnings miss expectations

Third quarter 2020 earnings released: EPS CL$4.30

At CL$1,099, Is It Time To Put Forus S.A. (SNSE:FORUS) On Your Watch List?

New 90-day high: CL$1,030

New 90-day low: CL$950

First half earnings released

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies